Guideline summary · Cardiovascular · 7 min read
Atrial fibrillation: stroke prevention
CHA₂DS₂-VA, DOACs first, and the AF-CARE framework.

Key points
- The 2024 ESC guideline uses CHA₂DS₂-VA, which removes female sex as a risk factor.
- Oral anticoagulation is recommended with a score of 2 or more and should be considered with a score of 1.
- DOACs are preferred over warfarin except with mechanical heart valves or moderate-to-severe mitral stenosis.
- Bleeding risk scores should not be used to decide against anticoagulation; treat modifiable bleeding risks instead.
- Antiplatelet therapy alone is not an alternative to anticoagulation for stroke prevention.
Summary based on the ESC guidelines for the management of atrial fibrillation (2024). A study aid, not a substitute for the current guideline or local protocols.
Sign in free to read the full textRelated
Video12-min outlineCoronary circulation in 12 minutes
Map each coronary artery to the myocardium and ECG leads it supplies.
Notes8 min readValvular heart disease: high-yield murmurs
Timing, location, radiation and the bedside manoeuvres that change them.
Video14-min outline
The 10-step ECG read
Rate, rhythm, axis, intervals and the patterns you must not miss.